[1]曹海利,孟巍,白彬.肝癌基因治疗研究新进展[J].介入放射学杂志,2008,(05):375.
　CAO Haili,MENG Wei,BAI Bin.New progress in research of gene therapy for hepatocellular carcinoma[J].journal interventional radiology,2008,(05):375.
点击复制

肝癌基因治疗研究新进展()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2008年05期
页码:
375
栏目:
综述
出版日期:
2008-05-15

文章信息/Info

Title:
New progress in research of gene therapy for hepatocellular carcinoma
作者:
曹海利; 孟巍; 白彬
１５００８６哈尔滨医科大学附属第二医院介入放射科
Author(s):
CAO Hai－li; MENG Wei; BAI Bin．
Department of Radiology，the Second Affiliated Hospital of Harbin Medical University，Harbin１５００８６，China．
关键词:
肝癌; 基因治疗; 基因转移; 癌基因
分类号:
R７３５.７
文献标志码:
A
摘要:
肝癌是我国常见的恶性肿瘤，目前治疗方法较多，其中基因治疗是当前热点问题。本文对肝癌基因治疗的几个方面：反义基因治疗、自杀基因治疗、免疫基因治疗、抑癌基因治疗、联合基因治疗、基因载体等方面进行了综述。

参考文献/References:

［１］Huber BE，Richards CA，Krenitsky TA．Retroviral－mediated gene therapy for the treatment of hepatocellular carcinoma ：an innovative approach for cancer therapy［J］．Proc Natl Acad Sci USA，１９９１，８８：８０３９－８０４３．
［２］Lin CQ，Li B，Zhang C，et al．Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma ［J］．Ann Oncol，２００５，１６：１０９－１１５．
［３］Penuelas I，Mazzolini G，Boan JF，et al，Positron emission graphy imaging of adenoviral－mediated transgene expression in liver cancer patients［J］．Gashaenterology，２００５，１２８：１７８７－１７９５．
［４］Zhang Y，Zhang Y，Chen J，et al．Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy［J］．Nanomedicine，２００７，３：１４４－１５３．
［５］Gerolami R，Cardoso J，Bralet MP ，et al．Enhanced in vivo adenovirus－mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery［J］．Gene Ther，１９９８，５：８９６－９０４．
［６］Wang XW，Yuan JH，Zhang RG，et al．Antihepatoma effect of alpha－fetoprotein antisense phosphorothioate oligodeoxyribonuc－leotides in vitro and in mice［J］．World J Gastroenterol，２００１，７：３４５－３５１．
［７］Sun Y，Lin R，Dai J，et al．Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice［J］．Oligonucleotides，２００６，１６：３６５－３７４．
［８］Cao L，Si J，Wang W，et al．Intracellular localization and sustained prodrug cell killing activity of TAT－HSVTK fusion protein in hepatocelullar carcinoma cells［J］．Mol Cells，２００６，２１：１０４－１１１．
［９］Harada Y，Iwai M，Tanaka S，et al．Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein－barr virus－based plasmid vectors combined with polyamidoamine dendrimer［J］．Cancer Gene Ther，２０００，７：２７－３６．
［１０］Won YS，Lee SW．Targeted retardation of hepatocarcinoma cells by specific replacement of alpha－fetoprotein RNA［J］．Biotechnol，２００７，１２９：６１４－６１９．
［１１］Martinet O，Ermekova V，QiaoJ Q，et al．Immunomodulatory gene therapy with interleukin１２and４－１BB ligand：longterm remission of liver metastases in a mouse model［J］．Natl Cancer Inst，２０００，９２：９３１－９３６．
［１２］Noboru H，Mitsuo S，Shinji O，et al．IL－１２gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice［J］．J Immunol，２００４，１７３：６６３５－６６４４．
［１３］Chang CY，Lee J，Kim EY，et al．Intratumoral delivery of IL－１８naked DNA induces T－cell activation and Th１response in a mouse hepatic cancer model［J］．BMC Cancer，２００７，７：８７．
［１４］Jicai Z，Zongtao Y，Jun L，et al．Persistent infection of hepatitisB virus is involved in high rate of p１６methylation in hepatocellular carcinoma ［J］．Mol Carcinog，２００６，４５：５３０－５３６．
［１５］Zhang YJ ，Rossner P Jr，Chen Y，et al．Aflatoxin B１and polyc－yclic aromatic hydrocarbon adducts，p５３mutations and p１６methylation in liver tissue and plasma of hepatocellular carcinoma patients［J］．Int J Cancer，２００６，１１９：９８５－９９１．
［１６］Okimoto T，Yahata H，Itou H，et al．Safely and growth suppre－ssive effect of intra－hepatic arterial injection of ADomv－P５３combined with CDDP to rat liver metastatic tumor［J］．J Exp Clin Cancer Res，２００３，２２：３９９－４０６．
［１７］Huang JZ，Xia SS，Ye QF，et al．Effects of p１６gene on biological behaviours in hepatocellular carcinoma cells［J］．World J Gastroenterol，２００３，９：８４－８８．
［１８］Drozdzik M，Qian C，Xie X，et al．Combined gene therapy with suicide gene and interleukin－１２is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma ［J］．Hepatology，２０００，３２：２７９－２８６．
［１９］Gu S，Liu CJ ，Qiao T，et al．Inhibitory effect of antisense vascular endothelial growth factor１６５eukaryotic expression vector on proliferation of hepatocellular carcinoma cells［J］．World J Gastroenterol，２００４，１０：５３５－５３９．
［２０］Azuma H，Tomita S，Kaneda Y，et al．Transfection of NK kappaB－decoy oligodeoxynucletides using efficient ultrasound mediated gene transfer into donor kidneys prolonged survival of renal allografts［J］．Gene Ther，２００３，１０：４１５－４２５．
［２１］Miller DL，Don C，Song J．DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro［J］．Ultrasound Med Biol，２００３，２９：６０１－６０７．
［２２］Hallenbeck PL，Chang YN，Hay C，et al．A novel tumor－specific replication restricted adenoviral vector for gene therapy of hepatocellular carcinoma ［J］．Hum Gene Ther，１９９９，１０：１７２１－１７３３．
［２３］Hernandez－Alcoceba R，Sangro B，Prieto J，et al．Gene therapy of liver cancer［J］．Ann Hepatol，２００７，６：５－１４．

相似文献/References:

[1]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
　LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].journal interventional radiology,2008,(05):514.
[2]杨伟洪,刘鹏程,梁珊瑚,等.多层螺旋CT血管造影在判断肝癌寄生供血中的价值[J].介入放射学杂志,2008,(09):654.
　YANG Weihong,LIU Pengchen g,LIANG Shanhu,et al.Evaluation of MSCTA for parasitic blood supply in hepatic carcinoma[J].journal interventional radiology,2008,(05):654.
[3]张茵,周兵,许秀芳,等.肝动脉化疗栓塞治疗原发性肝癌存活２０年一例[J].介入放射学杂志,2008,(09):684.
　ZHANG Yin,ZHOU Bing,XU Xiufang,et al.Survival more than２０years after transarterial chemical embolization for hepatocellular carcinoma：A case report[J].journal interventional radiology,2008,(05):684.
[4]官泳松,贺庆.肝癌介入治疗中应用p５３的几个要点[J].介入放射学杂志,2008,(11):761.
　GUAN Yongsong,HE Qing.Essentials in clinical application of p５３for tumors intervention－example of liver cancer[J].journal interventional radiology,2008,(05):761.
[5]肖运平,肖恩华.介入治疗在防治肝癌术后复发中的作用及进展[J].介入放射学杂志,2008,(11):831.
　XIAO Yunping,XIAO Enhua.The role and progress of interventional therapy in the prevention and treatment of postoperative hepatocellular carcinoma recurrence[J].journal interventional radiology,2008,(05):831.
[6]史震山,陈自谦,杨熙章,等.原发性大肝癌患者TACE后S－腺苷蛋氨酸的护肝作用[J].介入放射学杂志,2008,(11):790.
　SHI Zhenshan,CHEN Ziqian,YANG Xizhang,et al.The clinical study on the liver－protection of S－adenosy－methionine in large hepatocellular carcinoma patients after TACE[J].journal interventional radiology,2008,(05):790.
[7]王耀普,杨康健,赵思源,等.兔肝癌模型的改良接种及其DSA影像分析[J].介入放射学杂志,2010,(03):214.
　WANG Yaopu,YANG Kangjian,ZHAO Siyuan,et al.The modified inoculation method for the preparation of rabbit VX２hepatic carcinoma model and DSA imagining observation[J].journal interventional radiology,2010,(05):214.
[8]贺洪德,贺晶,罗中华,等.肝动脉化疗栓塞联合门静脉栓塞治疗中晚期肝癌的疗效评价[J].介入放射学杂志,2010,(03):191.
　HE Hongde,HE Jing,LUO Zhonghua,et al.Evaluation of the therapeutic effect of hepatic arterial chemoembolization combined with portal chemoembolization for advanced hepatic carcinomas[J].journal interventional radiology,2010,(05):191.
[9]李广琪,曹玮,李超,等.肝动脉热灌注对兔肝VX２肿瘤及正常肝组织血管渗透性功能的作用[J].介入放射学杂志,2010,(03):217.
　LI Guangqi,CAO Wei,LI Chao,et al.Influence of hepatic artery thermotherapy on the vascular permeability of hepatic tumor tissue and normal liver tissue in VX２tumor－bearing rabbits[J].journal interventional radiology,2010,(05):217.
[10]杨康健,赵思源,赵斌羽,等.兔肝癌改良接种模型的生长特性研究[J].介入放射学杂志,2010,(03):211.
　YANG Kangjian,ZHAO Siyuan,ZHAO Binyu,et al.The growing features of rabbit VX２hepatic carcinoma model prepared with modified inoculation method[J].journal interventional radiology,2010,(05):211.

备注/Memo

备注/Memo:
收稿日期：２００７－０８－１３
更新日期/Last Update: 2008-05-15